Furthermore, JMJD3 levels are elevated in patients with NEC and in neonatal mice subjected to experimental NEC, contributing to a pro-inflammatory response characterized by increased IL-6 and TNF-α release that drives NEC progression [23]. This evidence concerns the gene IL6 and necrotizing enterocolitis.